Post-Operative Pain-API Insights, 2017
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 84224
Related Topics: FDA , Pain

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Post-Operative
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Post-Operative Pain -API Insights, 2017 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Post-Operative Pain. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• A snapshot of the global Market therapeutics scenario for Post-Operative Pain.

• A review of the marketed products under prescription for Post-Operative Pain, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Post-Operative Pain with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Post-Operative Pain drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Post-Operative Pain drugs.

• Key discontinued Marketed products.

• Global Sales Figure from 2012-2016.Reasons to Buy

• Evaluate the marketing status and exclusivity details of Post-Operative Pain key products to exploit opportunities for generic drug development opportunities.

• Key players in the pharmaceutical industry.

•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Post-Operative Pain.

• API intelligence over marketed drugs for Post-Operative Pain and gaining primary intelligence over active ingredients manufacturers across the globe.

• Uncovering opportunities in the rapidly growing the US markets.

Table of Contents
for Post-Operative Pain-API Insights, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Post-Operative Pain-API Insights, 2017 [Report Updated: 30-05-2017]

Post-Operative Pain Therapeutic Market, US, Marketed Drugs by Application Type, 2017

Post-Operative Pain Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017

Post-Operative Pain Therapeutic Market, US, (Year), 2017

Post-Operative Pain Marketed Drugs, API Manufacturers by US DMF Status, 2017

Post-Operative Pain Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Post-Operative Pain Therapeutic Market, Global Sales (in million USD), 2017

Post-Operative Pain Marketed Drugs, API Manufacturers, Global, 2017

Discontinued Drugs for Post-Operative Pain, 2017

List Of Figures, Charts and Diagrams
in Post-Operative Pain-API Insights, 2017 [Report Updated: 30-05-2017]

Post-Operative Pain Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017

Post-Operative Pain Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017

Post-Operative Pain Therapeutic Market, US, (Year), 2017

Post-Operative Pain Marketed Drugs, API Manufacturers by US DMF Status (%), 2017

Post-Operative Pain Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Post-Operative Pain Therapeutic Market, Global Sales (in million USD), 2017

Post-Operative Pain Marketed Drugs, Patent/Exclusivity Expiry (Year), 2017

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

84224 | DII2017API146

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Post-Operative Pain Global Clinical Trials Review, H1, 2016
Post-Operative Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report...
16 Mar 2016 by Global Data USD $2,500 More Info
Post-Operative Pain Global Clinical Trials Review, H2, 2015
Post-Operative Pain Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report...
23 Dec 2015 by Global Data USD $2,500 More Info
Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015
Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
23 Dec 2015 by Global Data USD $2,500 More Info
Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015
Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinic...
16 Dec 2015 by Global Data USD $2,500 More Info
Post Menopausal Disorder Global Clinical Trials Review, H2, 2015
Post Menopausal Disorder Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial r...
04 Dec 2015 by Global Data USD $2,500 More Info
Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H2, 2015
Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H...
04 Dec 2015 by Global Data USD $2,500 More Info
Physician Views – Taking a post-ASCO pulse on the PD-L1 biomarker debate in non-small-cell lung cancer
ScopeThe data presented at this year's ASCO annual meeting, which has subsequently fuelled the most ...
01 Jun 2015 by FirstWord Pharma USD $695 More Info
Physician Views: A post-AdCom assessment of Novo Nordisk's liraglutide for obesity
Scope Novo Nordisk took an important step in its bid to enter the obesity market last week, when an ...
17 Sep 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Entering the post-interferon era – will Gilead Sciences dominate hepatitis C?
Scope Consensus forecasts indicate that Gilead Sciences will dominate the market for all oral, inter...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Post ADA view on key diabetes market developments
ScopeLast week’s American Diabetes Association (ADA) meeting provided further evidence that the diab...
01 Jul 2013 by FirstWord Pharma USD $695 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)